Modified Clostridial toxins with altered targeting capabilities for Clostridial toxin target cells

Details for Australian Patent Application No. 2012203366 (hide)

Owner Allergan, Inc.

Inventors Fernandez-Salas, Ester; Francis, Joseph; Li, Shengwen; Steward, Lance E.; Gilmore, Marcella A.; Aoki, Kei R.

Agent Davies Collison Cave

Pub. Number AU-A-2012203366

Parent 2006225116

Filing date 7 June 2012

Wipo publication date 28 June 2012

International Classifications

C07K 14/33 Peptides having more than 20 amino acids

Event Publications

28 June 2012 Application Open to Public Inspection

  Published as AU-A-2012203366

28 June 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012203367-System and method for storing and accessing electronic receipts

2012203365-Humanized antibodies against ICAM-1, their production and uses